v3.26.1
Reverse Takeover Transaction with NCAC - Schedule of Listing Expenses (Details) - NCAC [Member]
 12 Months Ended
Mar. 31, 2026
USD ($)
$ / shares
shares
Consideration paid:  
Shares issued to NCAC shareholders (in Shares) | shares 2,086
Total consideration shares issued (in Shares) | shares 2,086
Fair value of the common shares (in Dollars per share) | $ / shares $ 17,895.14
Deemed consideration amount for the common shares issued $ 37,336,416
Net identifiable liabilities acquired:  
Cash and cash equivalent 203
Accounts payable and accrued liabilities (2,136,505)
NCAC promissory note (Note 18) (1,413,529)
Derivative warrant liabilities (Note 13) (595,358)
Net liabilities acquired 4,145,189
Listing expense $ 41,481,605